AYTU BIOPHARMA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.22 USD | +0.31% |
|
+6.64% | +13.03% |
| 02-14 | Transcript : Aytu BioPharma, Inc., Q2 2024 Earnings Call, Feb 14, 2024 | |
| 02-14 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, vs. Street Est of $21.75M | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 3.360 | 3.360 | 3.220 |
| Spread/Res. | -4.46% | -4.46% | -0.31% |
| Spread/Supp. | +19.78% | +43.95% | +45.25% |
| Support | 2.680 | 2.230 | 2.210 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AYTU Stock
- Charts Aytu BioPharma, Inc.
